A detailed history of Prelude Capital Management, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 28,844 shares of SRRK stock, worth $884,645. This represents 0.08% of its overall portfolio holdings.

Number of Shares
28,844
Previous 23,944 20.46%
Holding current value
$884,645
Previous $1.03 Million 10.35%
% of portfolio
0.08%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$32.15 - $45.55 $157,535 - $223,195
4,900 Added 20.46%
28,844 $927,000
Q4 2024

Feb 14, 2025

SELL
$7.07 - $45.73 $127,260 - $823,140
-18,000 Reduced 42.91%
23,944 $1.03 Million
Q3 2024

Nov 14, 2024

BUY
$7.63 - $9.71 $320,032 - $407,276
41,944 New
41,944 $335,000
Q3 2019

Nov 14, 2019

SELL
$8.95 - $15.72 $3,687 - $6,476
-412 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$14.61 - $22.45 $6,019 - $9,249
412 New
412 $7,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.58B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.